NovaBay Pharmaceuticals, Inc.

Novabay Pharmaceuticals, Inc.

Biotechnology • Healthcare • Emeryville, CA, United States • NBY (ASE)

NovaBay Pharmaceuticals, Inc. manufactures and sells wound care products. The company offers hypochlorous acid for use in the cleansing and irrigation of post-surgical wounds, minor burns, and superficial abrasions. It sells its products to its distribution partners in China. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

510 899 8800 2000 Powell Street, Emeryville, CA 94608, United States Wikipedia

Stock Performance (90 Days)

Data through Dec 29, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Short Interest Update - MarketBeat
MarketBeat • Dec 25
NovaBay Pharmaceuticals, Inc. (NBY) Declares $0.80 Special Dividend, Boosting Shareholder Value - Yahoo Finance
Yahoo Finance • Sep 23
NovaBay Pharmaceuticals Faces Growth Challenges Amidst Financial Instabilities - StocksToTrade
StocksToTrade • Sep 6
NovaBay Pharmaceuticals CEO David Lazar to resign following stock transfer agreement - Investing.com
Investing.com • Oct 9
NovaBay Pharmaceuticals Stock Surges Amid Financial Resilience - timothysykes.com
timothysykes.com • Sep 7

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has NovaBay Pharmaceuticals, Inc. had layoffs?
No layoff events have been recorded for NovaBay Pharmaceuticals, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does NovaBay Pharmaceuticals, Inc. have?
NovaBay Pharmaceuticals, Inc. has approximately 13 employees.
What industry is NovaBay Pharmaceuticals, Inc. in?
NovaBay Pharmaceuticals, Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is NovaBay Pharmaceuticals, Inc. a publicly traded company?
Yes, NovaBay Pharmaceuticals, Inc. is publicly traded under the ticker symbol NBY on the ASE. The company has a market capitalization of approximately $0.61 billion.
Where is NovaBay Pharmaceuticals, Inc. headquartered?
NovaBay Pharmaceuticals, Inc. is headquartered in Emeryville, CA, United States at 2000 Powell Street, Emeryville, CA 94608, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.